Healthcare - Medical - Devices - NASDAQ - US
$ 1.8
1.12 %
$ 7.87 M
Market Cap
-0.01
P/E
CASH FLOW STATEMENT
-17.9 M
OPERATING CASH FLOW
330 K
INVESTING CASH FLOW
3.68 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Nuwellis, Inc.
| Net Income | -20.2 M |
| Depreciation & Amortization | 362 K |
| Capital Expenditures | -248 K |
| Stock-Based Compensation | 670 K |
| Change in Working Capital | -1.42 M |
| Others | 2.59 M |
| Free Cash Flow | -18.2 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Jun-2011 | Jun-2009 | Jun-2008 | Jun-2007 | Jun-2006 | Jun-2005 | Jun-2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||||||
| Net Income | (20.2) | (14.5) | (19.6) | (15.8) | (18.1) | (17.0) | (13.4) | (15.8) | (26.6) | (25.6) | (21.8) | (14.1) | (16.2) | (5.6) | (6.5) | (9.3) | (9.8) | (5.2) | (3.8) | (1.0) |
| Depreciation & Amortization | 0.4 | 0.4 | 0.5 | 0.4 | 0.2 | 0.2 | 0.8 | 0.7 | 0.3 | 0.3 | 0.2 | 0.1 | 50 K | 51.2 K | 56.3 K | 74.9 K | 54.5 K | 34.4 K | 28.5 K | 23.5 K |
| Deferred Income Tax | 0 | 0 | (2.5) | 0 | (2.1) | 0 | 0 | (0.3) | 0 | (2.7) | (3.0) | (1.2) | 50 K | 0.000001 | 51.9 K | 35.2 K | 11.1 K | (0.2) | 0 | 0 |
| Stock Based Compensation | 0.7 | 0.9 | 1.3 | 1.3 | 1.5 | 2.1 | 0.5 | 0.9 | 2.2 | 2.7 | 3.0 | 1.2 | 0.9 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 2.7 | (2.5) | 2.5 | (1.2) | 2.1 | 2.3 | 2.5 | 0.2 | 0.3 | 2.7 | 3.2 | 1.5 | 50 K | 39.1 K | 56.3 K | 4.44 K | 54.5 K | 0.2 | 0 | 0.000001 |
| Change in Working Capital | (1.4) | 0.6 | (0.1) | (1.3) | 4 K | 0.2 | (2.3) | (2.0) | 0.9 | 12 K | 1.0 | (0.7) | 2.1 | (0.7) | 67.4 K | 0.1 | 0.9 | 0.3 | (1.1) | (0.2) |
| Cash From Operations | (17.9) | (15.1) | (17.9) | (16.6) | (16.4) | (14.6) | (11.9) | (16.3) | (23.0) | (22.6) | (17.4) | (13.1) | (13.1) | (6.2) | (6.3) | (8.8) | (8.5) | (4.7) | (4.8) | (1.2) |
| INVESTING CASH FLOW | ||||||||||||||||||||
| Capital Expenditures | (0.2) | (0.1) | (0.2) | (0.3) | (0.5) | (0.2) | (0.3) | (0.1) | (0.2) | (0.4) | (0.3) | (0.2) | (0.5) | 4.34 K | 6.91 K | 8.5 K | (0.1) | 90.1 K | 78 K | 9.55 K |
| Other Items | 0.6 | 14.8 | 0 | 31 K | 0 | 0 | 0 | (4.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 0.3 | 14.7 | (0.2) | (0.3) | (0.5) | (0.2) | (0.3) | (4.1) | (0.2) | (0.4) | (0.3) | (0.2) | (0.5) | 4.34 K | 6.91 K | 8.5 K | (0.1) | 90.1 K | 78 K | 9.55 K |
| FINANCING CASH FLOW | ||||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | 0 | (0.3) | 0 | 0 |
| Total Debt Repaid | 28 K | 26 K | 26 K | 20 K | 0 | 0 | 0 | (8.0) | 8.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.6 | 0 | 1 K | 4.1 | 0 | 0 | 2.2 | 6.6 | 7.1 | 0 | 0 | 0 | 0 | (1.3) | (0.5) | 0.000001 | (0.2) | 0 | (0.2) | (1.5) |
| Cash From Financing Activities | 3.7 | 9.4 | 27.9 | 30.0 | 12.7 | 4.6 | 26.5 | (1.4) | 15.1 | 89 K | 57.6 | 20.8 | 7.6 | 7.9 | 0 | 10.7 | 11.4 | 2.3 | 9.9 | 1.0 |
| CHANGE IN CASH | ||||||||||||||||||||
| Net Change In Cash | (13.9) | 9.0 | 9.8 | 13.2 | (4.2) | (10.1) | 14.3 | (21.8) | (8.2) | (22.8) | 39.9 | 7.7 | (5.8) | 1.6 | (6.3) | 2.0 | 2.7 | (2.5) | 5.0 | (0.3) |
| FREE CASH FLOW | ||||||||||||||||||||
| Free Cash Flow | (18.2) | (15.3) | (18.1) | (16.9) | (16.9) | (14.8) | (12.2) | (16.4) | (23.2) | (23.0) | (17.7) | (13.2) | (13.5) | (6.2) | (6.3) | (8.8) | (8.6) | (4.8) | (4.9) | (1.2) |